两家印度制药公司因质量问题召回美国药品, Two Indian drugmakers recall U.S. medications over quality issues, per FDA oversight.

两位印度毒品制造者, Reddy博士和Zydus生命科学, 正在美国就质量问题回忆药物。 Two Indian drugmakers, Dr Reddy's and Zydus Lifesciences, are recalling medications in the U.S. over quality issues. 由于稳定性测试失败，Dr Reddy's 正在召回 571 瓶琥珀酰氯胆碱注射液，这是影响整个美国市场的 II 类召回。 Dr Reddy's is recalling 571 vials of Succinylcholine Chloride Injection due to failed stability tests, a Class II recall affecting the entire U.S. market. Zydus将1 500多箱Entecavir片片用于处理杂质和退化问题。 Zydus is recalling over 1,500 boxes of Entecavir tablets for impurity and degradation problems. 两项召回均由美国FDA监督促成, 突出显示印度制造的药品质量正在持续检查, 印度在美国以外的制造设施中符合FDA的要求最多. Both recalls, prompted by U.S. FDA oversight, highlight ongoing quality checks on drugs made in India, which has the most FDA-compliant manufacturing facilities outside the U.S.